SAWS
AAM Sawgrass US Small Cap Quality Growth ETF
The AAM Sawgrass US Small Cap Quality Growth ETF seeks to invest in high-quality U.S. small-cap companies that demonstrate strong fundamentals and growth potential.
US
EQUITY
Active
MANAGEMENT STYLE
$ 7.8 M
ASSETS UNDER MGMT
55 bp
EXPENSES
Fund Basics
| Inception date | Jul 30, 2024 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| STONEX GROUP INC | 5.6 % |
| BRIGHTSPRING HEALTH SERVICES, INC. | 3.8 % |
| PRICESMART INC | 3.2 % |
| IRADIMED CORP | 3.1 % |
| ARCHROCK INC. | 3.0 % |
| GUARDIAN PHRMCY SERVICES-A | 2.9 % |
| GORMAN-RUPP CO | 2.6 % |
| A10 NETWORKS INC | 2.5 % |
| SANMINA CORP | 2.4 % |
| ENOVA INTERNATIONAL INC | 2.3 % |
Constituent Breakdown
| Number of holdings | 72 |
| Herfindahl-Hirschman Index | 203 |
| Wgt avg mkt cap (mns) | $6,098 |
| Large cap (>$10bn) | 16.5% |
| Mid cap ($2-10bn) | 64.6% |
| Small cap (<$2bn) | 20.9% |
| Developed mkts. | 102.0% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 101.3 % |
 |
CANADA | 0.7 % |
Historical Performance
Standardized Performance (as of 06/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 23.4% | 32.3% | -- | -- | -- | -- | -- | 2.5% |
| Dividend Yield | 0.0% | 0.0% | -- | -- | -- | -- | -- | 0.0% |
| Total Returns | 23.4% | 32.3% | -- | -- | -- | -- | -- | 2.5% | Ann. Volatility | 20.4% | 19.0% | -- | -- | -- | -- | -- | 27.2% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.08 | 50% |
| MSCI EAFE | 0.80 | 42% |
| MSCI Emg Mkts | 0.51 | 37% |
Liquidity Measures
| Avg. volume (000) | 3 |
| ADV traded (mns) | $0 |
| Turnover | 0.9% |
| Avg. Bid/Ask (% of price) | 0.09% |
Technical Indicators
| 30d moving avg. (EMA) | $24.71 |
| Relative strength (RSI) | 52 |
| MACD/Signal | 0.07/0.23 |
| Bollinger Bands (Upper/Lower) | $26.12/$24.27 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. SAWS |
Expenses vs. SAWS |
ALTAR Score™ vs. SAWS |
|---|---|---|---|---|
| XSMO | Invesco S&P SmallCap Momentum ETF | 25.5% | -16 bp | +0.4% |
| RZG | Invesco S&P Smallcap 600 Pure Growth ETF | 21.2% | -20 bp | +0.3% |
| CAFG | Pacer US Small Cap Cash Cows Growth Leaders ETF | 19.2% | +4 bp | +0.8% |
| VIOG | Vanguard S&P Small-Cap 600 Growth ETF | 17.2% | -45 bp | +0.3% |
| JSML | Janus Henderson Small Cap Growth Alpha ETF | 16.2% | -25 bp | -0.2% |
| SLYG | State Street SPDR S&P 600 Small Cap Growth ETF | 16.0% | -40 bp | +0.4% |
| IJT | iShares S&P Small-Cap 600 Growth ETF | 15.8% | -37 bp | +0.4% |
| DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 15.1% | +5 bp | -4.4% |
| DBSC | Deepwater Beachfront Small Cap ETF | 14.7% | +30 bp | -1.6% |
| RSMC | Rockefeller U.S. Small-Mid Cap ETF | 13.7% | +20 bp | +1.0% |
Risk and Returns: SAWS vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 7/21/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
4.0%
ALTAR SCORE™
25th
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 1,398 funds in the US Equity category with an average
ALTAR Score™ of 5.4% and a standard deviation
of 2.1%. SAWS's ALTAR Score™ is approximately -0.7 standard
deviations above the category average. This places SAWS in the 25th percentile
among funds in the category.
Sell-Side Consensus
$23.73
PRICE TARGET
-2.6%
UPSIDE